Christine P. Bono - Concepedia

Author

Christine P. Bono

Washington University in St. Louis

Also Known As

C Bono, C P Bono, C. Bono, C.P Bono, C.P. Bono, Christine Bono, Christine P Bono, Christine P. Bono

Publications

502

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis Pfizer (United States)Parkway School District

About

Christine P. Bono is an author at Washington University in St. Louis specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	354
2	Natural Sciences	4	4	84
3	Allergy	3	3	54
4	Biochemistry	3	3	60
5	Allergy Medicine	1	1	25

Christine P. Bono

Publications

447

Citations

H-Index

Page 1

	Year	Citations
Missing data on the Center for Epidemiologic Studies Depression Scale: A comparison of 4 imputation techniques Christine P. Bono, L. Douglas Ried, Carole L. Kimberlin, Research in Social and Administrative Pharmacy Family MedicinePsychological Co-morbiditiesPsychiatryMood SymptomDepression	2007	161
Pocket 4 of the HLA-DR(α,β 1*0401) molecule is a major determinant of T cells recognition of peptide. X T Fu, Christine P. Bono, Susan L. Woulfe, The Journal of Experimental Medicine HistocompatibilityReverse GeneticsHla ImmunogeneticsImmunologyMolecular Biology	1995	103
Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401 Susan L. Woulfe, Christine P. Bono, Michelle L. Zacheis, Arthritis & Rheumatism	1995	28
Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS) Chris P. Carron, John I. Trujillo, Kirk L. Olson, ACS Medicinal Chemistry Letters AsthmaAllergy MedicineMast Cell DisorderImmunologyPharmacotherapy	2010	25
Design of MHC class II (DR4) ligands using conformationally restricted imino acids at p3 and p5 Gunnar J. Hanson, Jennifer L. Vuletich, Louis J. Bedell, Bioorganic & Medicinal Chemistry Letters Inorganic ChemistryInorganic SynthesisMedicineNatural SciencesCoordination Complex	1996	24
Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): A tale of two waters John I. Trujillo, James R. Kiefer, Wei Huang, Bioorganic & Medicinal Chemistry Letters Human Hematopoietic ProstaglandinBiochemistryG Protein-coupled ReceptorNatural SciencesProteomics	2012	23
Peptide binding to surface class II molecules is the major pathway of formation of immunogenic class II-peptide complexes for viable antigen presenting cells. N R Nygard, K S Giacoletto, Christine P. Bono, The Journal of Immunology Class IiMajor PathwayPeptide EngineeringHla ImmunogeneticsImmunology	1994	18
Receptor occupancy and blocking of STAT5 signaling by an anti‐<scp>IL</scp>‐7 receptor α antibody in cynomolgus monkeys Brent Kern, Wenlin Li, Christine P. Bono, Cytometry Part B Clinical Cytometry	2015	17
Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition Lawrence R. Brown, N R Nygard, Mary Beth Graham, The Journal of Immunology	1991	15
Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides Sudhir Agrawal, Ekambar R. Kandimalla, Yu Dong, International Journal of Oncology Bioorganic ChemistryAntitumor ActivityPharmacotherapyPharmaceutical ChemistryTumor Biology	2001	12

Page 1